Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap due to Oral Temozolomide and Cranial Radiotherapy

被引：0
作者：
Nilendu Sarma
机构：
[1] NRS Medical College,
[2] P N Colony,undefined
[3] Sapuipara,undefined
[4] Bally,undefined
来源：
American Journal of Clinical Dermatology | 2009年 / 10卷
关键词：
Temozolomide; Glioblastoma Multiforme; Toxic Epidermal Necrolysis; Malignant Fibrous Histiocytoma; Cranial Radiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A 46-year-old man developed Stevens-Johnson syndrome and toxic epidermal necrolysis overlap, with severe localized denudation of the skin on the head and neck, following radiotherapy and oral temozolomide therapy for cranial glioblastoma multiforme. He also had a primary malignant fibrous histiocytoma of the thigh that was amputated 5 years earlier.
引用
收藏
页码：264 / 267
页数：3
相关论文
共 50 条
  • [31] Adefovir dipivoxilFirst report of Stevens-Johnson syndrome and toxic epidermal necrolysis overlap syndrome: case report
    [J]. Reactions Weekly, 2011, 1361 (1) : 5 - 5
  • [32] Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
    Fritsch P.O.
    Sidoroff A.
    [J]. American Journal of Clinical Dermatology, 2000, 1 (6) : 349 - 360
  • [33] Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Cheng, Lin
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy
    Valeyrie-Allanore, Laurence
    Poulalhon, Nicolas
    Fagot, Jean-Paul
    Sekula, Peggy
    Davidovici, Batya
    Sidoroff, Alexis
    Mockenhaupt, Maja
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 87 (02) : 300 - 303
  • [35] Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: a Review and Update
    Jennifer L. Coias
    Laila F. Abbas
    Adela R. Cardones
    [J]. Current Dermatology Reports, 2019, 8 : 219 - 233
  • [36] Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel
    Maggio, Nicola
    Firer, Maria
    Zaid, Huda
    Bederovsky, Yana
    Aboukaoud, Mohammed
    Gandelman-Marton, Revital
    Noyman, Iris
    Ekstein, Dana
    Blatt, Ilan
    Marom, Eli
    Schwartzberg, Eyal
    Israel, Shoshana
    Ingber, Arieh
    Brautbar, Chaim
    Eyal, Sara
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07) : 823 - 829
  • [37] Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Setting of Daptomycin Administration
    Repetsky, Christopher D.
    Morehart, Candice Rae
    Henning, Ania K.
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2022, 30 (03)
  • [38] Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options
    Worswick, Scott
    Cotliar, Jonathan
    [J]. DERMATOLOGIC THERAPY, 2011, 24 (02) : 207 - 218
  • [39] Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children
    Finkelstein, Yaron
    Soon, Gordon S.
    Acuna, Patrick
    George, Mathew
    Pope, Elena
    Ito, Shinya
    Shear, Neil H.
    Koren, Gideon
    Shannon, Michael W.
    Garcia-Bournissen, Facundo
    [J]. PEDIATRICS, 2011, 128 (04) : 723 - 728
  • [40] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Improving the Support to Victims
    Roujeau, Jean-Claude
    [J]. DRUG SAFETY, 2013, 36 (02) : 145 - 146
12345